1. Home
  2. VIRT vs GUTS Comparison

VIRT vs GUTS Comparison

Compare VIRT & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIRT
  • GUTS
  • Stock Information
  • Founded
  • VIRT 2008
  • GUTS 2010
  • Country
  • VIRT United States
  • GUTS United States
  • Employees
  • VIRT N/A
  • GUTS N/A
  • Industry
  • VIRT Investment Bankers/Brokers/Service
  • GUTS
  • Sector
  • VIRT Finance
  • GUTS
  • Exchange
  • VIRT Nasdaq
  • GUTS NYSE
  • Market Cap
  • VIRT N/A
  • GUTS 110.1M
  • IPO Year
  • VIRT 2015
  • GUTS 2024
  • Fundamental
  • Price
  • VIRT $36.61
  • GUTS $1.93
  • Analyst Decision
  • VIRT Buy
  • GUTS Buy
  • Analyst Count
  • VIRT 7
  • GUTS 2
  • Target Price
  • VIRT $29.50
  • GUTS $18.00
  • AVG Volume (30 Days)
  • VIRT 859.6K
  • GUTS 287.3K
  • Earning Date
  • VIRT 01-23-2025
  • GUTS 02-02-2025
  • Dividend Yield
  • VIRT 2.62%
  • GUTS N/A
  • EPS Growth
  • VIRT 23.01
  • GUTS N/A
  • EPS
  • VIRT 1.98
  • GUTS N/A
  • Revenue
  • VIRT $1,910,017,000.00
  • GUTS $97,000.00
  • Revenue This Year
  • VIRT N/A
  • GUTS N/A
  • Revenue Next Year
  • VIRT $2.12
  • GUTS N/A
  • P/E Ratio
  • VIRT $18.46
  • GUTS N/A
  • Revenue Growth
  • VIRT 10.60
  • GUTS N/A
  • 52 Week Low
  • VIRT $16.02
  • GUTS $1.74
  • 52 Week High
  • VIRT $38.45
  • GUTS $14.50
  • Technical
  • Relative Strength Index (RSI)
  • VIRT 55.28
  • GUTS 44.11
  • Support Level
  • VIRT $34.15
  • GUTS $1.75
  • Resistance Level
  • VIRT $37.02
  • GUTS $2.11
  • Average True Range (ATR)
  • VIRT 1.01
  • GUTS 0.18
  • MACD
  • VIRT -0.08
  • GUTS -0.01
  • Stochastic Oscillator
  • VIRT 64.57
  • GUTS 26.51

About GUTS FRACTYL HEALTH INC

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Share on Social Networks: